Profile data is unavailable for this security.
About the company
Shanghai Haohai Biological Technology Co Ltd is a China-based company mainly engaged in the production and sale of biological products, medical hyaluronic acid and intraocular lenses, research and development of bioengineering and pharmaceuticals, and provision of related services. The ophthalmology business has covered cataract treatment, myopia prevention and control, refractive correction, ocular surface medication, and optometry materials such as intraocular lenses and orthokeratology lenses. Medical beauty and wound care products include hyaluronic acid dermal fillers, hyaluronic acid gel for skin and mucosal superficial tissue supplementation. Orthopedic products include orthopedic joint cavity viscoelastic supplements and others. Anti-adhesion and hemostasis products include medical chitosan (for anti-adhesion), medical sodium hyaluronate gel and collagen sponge. The Company mainly conducts its businesses in domestic and foreign markets.
- Revenue in HKD (TTM)2.92bn
- Net income in HKD448.76m
- Incorporated2007
- Employees2.16k
- LocationShanghai Haohai Biological Technology Co Ltd4F, No 2 Building, Alley 139Anshun Road, Changning DistrictSHANGHAI 200336ChinaCHN
- Phone+86 2 152293555
- Fax+86 2 152293558
- Websitehttps://www.3healthcare.com/
| Holder | Shares | % Held |
|---|---|---|
| Prudence Investment Management (Hong Kong) Ltd.as of 31 Dec 2024 | 1.97m | 5.40% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 1.59m | 4.36% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 399.64k | 1.10% |
| Vanguard Asset Management Ltd.as of 31 Dec 2025 | 68.86k | 0.19% |
| SSgA Funds Management, Inc.as of 05 Feb 2026 | 60.98k | 0.17% |
| Asset Management One Co., Ltd.as of 25 Nov 2024 | 46.20k | 0.13% |
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2025 | 36.50k | 0.10% |
| Vanguard Fiduciary Trust Co.as of 30 Nov 2025 | 30.44k | 0.08% |
| Andbank Wealth Management SGIIC SAUas of 30 Jun 2025 | 26.03k | 0.07% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 22.40k | 0.06% |
